掌阅科技(603533.SH):已经将相关的AI阅读思路、技术深度融合在公司阅读主APP“掌阅”之中
格隆汇7月19日丨掌阅科技(603533.SH)在投资者互动平台表示,“阅爱聊”是公司数字阅读产品与AI大模型相结合的MVP(最小化可行产品)。该产品的成功开发,让公司快速验证了AI阅读的产品原型,该产品不再单独升级迭代,公司已经将相关的AI阅读思路、技术深度融合在公司阅读主APP“掌阅”之中。目前与AI大模型深度融合的“掌阅”APP正在小范围用户测试之中,请您关注公司AI阅读官方公众号“掌阅AI阅”,按照里面的指引申请加入内测,以获取高品质的智能阅读体验。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.